These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
111 related articles for article (PubMed ID: 25433065)
21. Clinical practice. Secondary prevention after ischemic stroke or transient ischemic attack. Davis SM; Donnan GA N Engl J Med; 2012 May; 366(20):1914-22. PubMed ID: 22591297 [No Abstract] [Full Text] [Related]
22. Tailored antiplatelet therapy for secondary prevention of ischemic stroke: myth or a desirable approach? Bertelli M; Luongo R; Barcella L; Cavalli P Panminerva Med; 2008 Sep; 50(3):260-1. PubMed ID: 18927532 [No Abstract] [Full Text] [Related]
23. Update on the treatment and prevention of ischaemic stroke. Alberts MJ Curr Med Res Opin; 2003; 19(5):438-41. PubMed ID: 13678483 [TBL] [Abstract][Full Text] [Related]
24. Risk factors and treatment of stroke at the time of recurrence. Laloux P; Lemonnier F; Jamart J Acta Neurol Belg; 2010 Dec; 110(4):299-302. PubMed ID: 21305857 [TBL] [Abstract][Full Text] [Related]
25. Epidemiological implications of primary and secondary stroke prevention. Bejot Y; Giroud M Handb Clin Neurol; 2009; 92():389-405. PubMed ID: 18790286 [No Abstract] [Full Text] [Related]
26. The role of antithrombotics in secondary stroke prevention. Lazzaro MA; Malhotra K; Mohammad YM Semin Neurol; 2010 Nov; 30(5):492-500. PubMed ID: 21207341 [TBL] [Abstract][Full Text] [Related]
28. Statin therapy in the secondary prevention of cerebrovascular events: is it really beneficial in clinical practice? Mascitelli L; Pezzetta F; Goldstein MR Med Hypotheses; 2010 Feb; 74(2):398. PubMed ID: 19733010 [No Abstract] [Full Text] [Related]
29. New ways to assess stroke risk and tame an abnormal heartbeat. Cardiology groups update guidelines to treat atrial fibrillation. Johns Hopkins Med Lett Health After 50; 2014 Jul; 26(6):1-2. PubMed ID: 25178120 [No Abstract] [Full Text] [Related]
30. Contra: "New oral anticoagulants should not be used as 1st choice for secondary stroke prevention in atrial fibrillation". Stöllberger C; Finsterer J Thromb Haemost; 2013 Sep; 110(3):496-500. PubMed ID: 23803875 [No Abstract] [Full Text] [Related]
32. [Prevention of stroke]. Endres M Drug Res (Stuttg); 2013 Nov; 63 Suppl 1():S14-5. PubMed ID: 24242030 [No Abstract] [Full Text] [Related]
33. Secondary prevention of heart disease and stroke: work to do. Heagerty AM Lancet; 2011 Oct; 378(9798):1200-2. PubMed ID: 21872919 [No Abstract] [Full Text] [Related]
34. Non-vitamin K antagonist oral anticoagulants in cardiovascular disease management: evidence and unanswered questions. Cheng JW; Barillari G J Clin Pharm Ther; 2014 Apr; 39(2):118-35. PubMed ID: 24383983 [TBL] [Abstract][Full Text] [Related]
35. Cardioembolic stroke: call for a multidisciplinary approach. Babarro EG; Rego AR; González-Juanatey JR Cerebrovasc Dis; 2009; 27 Suppl 1():82-7. PubMed ID: 19342836 [TBL] [Abstract][Full Text] [Related]
36. Preventing recurrent cerebrovascular events in patients with stroke or transient ischemic attack: the current data. Bergman D J Am Acad Nurse Pract; 2011 Dec; 23(12):659-66. PubMed ID: 22145656 [TBL] [Abstract][Full Text] [Related]
38. Preventing strokes: the assessment and management of people with transient ischaemic attack. Gommans J; Barber PA; Fink J N Z Med J; 2009 Apr; 122(1293):3556. PubMed ID: 19448791 [TBL] [Abstract][Full Text] [Related]
39. The utility of cardiovascular drugs in the treatment of cerebrovascular disease. Bösel J; Amiri H Curr Opin Investig Drugs; 2010 Sep; 11(9):1015-24. PubMed ID: 20730696 [TBL] [Abstract][Full Text] [Related]
40. Atrial fibrillation and stroke prevention: brief observations on the last decade. Lip GY Expert Rev Cardiovasc Ther; 2014 Apr; 12(4):403-6. PubMed ID: 24650307 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]